Insilico Sees Rising Revenue From Deals With AI Firms

Alex Zhavoronkov, Founder & CEO at Insilico Medicine, discusses the AI-drug discovery firm's earnings and business outlook exclusively on "Bloomberg: The China Show." (Source: Bloomberg)